Skip to content

Dokters Cooreman - Dooms

Active
Private limited companyfounded 2008active for 18 yearsRotspoelstraat 28, 3001 Leuven, BelgiumKBO/BCE: BE 0807.628.235
Summary

Dokters Cooreman - Dooms has been active since 2008 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €237,689 and a net result of €37,030. Equity has been stable since 2019 (±1.2% per year). Its solvency ranks better than 95% of 20,706 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 30-10-2008 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.193.299.761 3001 Leuven, since 30-10-2008
Financial year end
31 December
Peppol
Reachable since 18-03-2025

Financial position

96 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€55,369
▼ 28.6%
Turnover
≈ €120,000
estimated
Profit
€37,030
▼ 25.3%
Equity
€237,689
▲ 18.0%
Total assets
€241,485
▲ 18.3%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 75.06, cash €88,902Equity €237,689 (98.4% of total assets)Figures for financial year 2025 (filed on 30-06-2026)Show the evidence

Checked score

Score 2025
96 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 67% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 98.4% of total assets
Liquidity 96-4
short-term debt 1.3% · cash 36.8%
Profitability 88-11
return on assets 15.3%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: 0.1%▲ +0.1 percentage points vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.2%▲ +0.1 percentage points vs 06-2025highest value 08-2025: < 0.1%▼ -0.2 percentage points vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €22,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 75.06 (95.81 in 2024), above the usual 1.5. Short-term debt is 1.3% and cash 36.8% of total assets. 1.6% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 82% of them on solvency, 84% on liquidity, 41% on profitability and 62% on growth.

The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 75.06, cash €88,902
NBB · annual accounts
lowers risk · Equity €237,689 (98.4% of total assets)
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 30-06-2026)
NBB · annual accounts
lowers risk · Growing equity
Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.
NBB · annual accounts 2025
Equity per financial year
19202122232425
2019 to 2025 · latest year €237,689
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
31 days early
2024
14 days early
2023
2 days early
2022
28 days early
2021
26 days early
2020
18 days early
2019
46 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 24 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Where today falls in the filing period
03-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 95% of companies in human healthsector median 63.0% · 20,706 companies 98.4% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 7 profitable years in a rowprofit 2025: €37,030 7 years View

Recent changes

  1. · Gazette deed Company renamed from DR.LEE COOREMAN,psychiatrie to Dokters Cooreman–DoomsChange of role: COOREMAN Lee Kim, from manager to director · Appointment: DOOMS Christophe Alfons Vital Marc (bijkomende niet statutaire bestuurder)
  2. · Gazette deed Incorporation
All 18 events

Comparable companies

These companies have the same main activity as Dokters Cooreman - Dooms: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €215,000 and €291,000, founded between 2006 and 2011.

CompanyTotal assetsGross margin
Dokters Cooreman - Dooms Leuven€241,485€55,369
Dokter R. CLAEYS, klinische biologie Scherpenheuvel-Zichem€236,931€51,585
BREMPTALLERGY Marche-en-Famenne€224,849€59,563
MARKANGE Brussel€214,806€54,265
ANTALES Eghezée€272,773€54,957
Dr. Ingrid Monsieur Halle€261,019€59,439
DOKTER DIETER PODEVYN - ALGEMENE GENEESKUNDE Asse€290,503€54,585
Full comparison

Key facts about Dokters Cooreman - Dooms

What is the company number of Dokters Cooreman - Dooms?
The company number of Dokters Cooreman - Dooms is 0807.628.235. The VAT number is the same number with BE in front: BE 0807.628.235.
Where is Dokters Cooreman - Dooms based?
The registered office is at Rotspoelstraat 28, 3001 Leuven.Company details
What does Dokters Cooreman - Dooms do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dokters Cooreman - Dooms?
The legal form of Dokters Cooreman - Dooms is Private limited company (BV).
When was Dokters Cooreman - Dooms founded?
Dokters Cooreman - Dooms was founded on 30-10-2008.
Is Dokters Cooreman - Dooms still active?
Yes, Dokters Cooreman - Dooms is an active enterprise in the KBO register.
What is the turnover of Dokters Cooreman - Dooms?
The turnover in financial year 2025 is ≈ €120,000. This figure is estimated from the gross margin of €55,369 and 32 comparable companies (NACE 862). It probably lies between €96,000 and €160,000.Financials
Is Dokters Cooreman - Dooms profitable?
In financial year 2025, Dokters Cooreman - Dooms made a profit of €37,030.
Where can I find the annual accounts of Dokters Cooreman - Dooms?
Dokters Cooreman - Dooms filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dokters Cooreman - Dooms due?
Dokters Cooreman - Dooms must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.